Sands Capital Ventures, LLC Candel Therapeutics, Inc. Transaction History
Sands Capital Ventures, LLC
- $313 Million
- Q1 2024
A detailed history of Sands Capital Ventures, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 811,737 shares of CADL stock, worth $5.03 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
811,737
Previous 811,737
-0.0%
Holding current value
$5.03 Million
Previous $1.19 Million
7.46%
% of portfolio
0.41%
Previous 0.41%
Shares
2 transactions
Others Institutions Holding CADL
# of Institutions
22Shares Held
3.86MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC1.94MShares$12 Million8.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA541KShares$3.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$903,3770.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX82.6KShares$512,0890.0% of portfolio
-
Baystate Wealth Management LLC76.9KShares$476,8420.01% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $179M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...